课题基金 / 基金详情

Clinical Core

Clinical Core
临床核心
批准号:
9353007
负责人:
NED C SACKTOR
金额:
$36.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-06-16 至
关键词:
AIDS clinical trial groupAcquired Immunodeficiency SyndromeAgeAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAreaBaltimoreBehavioralBiological MarkersCellular StressCerebrospinal FluidClinicalClinical DataClinical ResearchClinical TreatmentClinical TrialsCognition DisordersCollaborationsConduct Clinical TrialsCost SavingsDataDevelopmentDistrict of ColumbiaDrug TargetingEnergy MetabolismEnsureEpidemicEvaluationFluconazoleFunctional Magnetic Resonance ImagingFunctional disorderFundingGlutamatesGoalsGrantHIVHIV InfectionsHIV SeronegativityHIV-associated neurocognitive disorderHuman immunodeficiency virus testImpaired cognitionIn VitroIndividualInfectionInstitutionInsulinInterventionLaboratoriesLaboratory MarkersLinkMagnetic Resonance SpectroscopyMaintenanceMeasuresMental HealthModelingMulticenter StudiesNational Institute of Mental HealthNeurocognitiveNeurocognitive DeficitNeurologicNeuromodulatorNeuronal InjuryNeuropsychological TestsNeuropsychologyOptical Coherence TomographyOutcomeOutcome MeasureOxidative StressParoxetineParticipantPatientsPerformancePersonsPhasePlasmaPlayPositron-Emission TomographyPrevalenceRecruitment ActivityRegulationResearch InfrastructureResearch InstituteResource SharingResourcesRisk BehaviorsRoleSIVSafetySample SizeServicesSourceSpecific qualifier valueSpecimenSphingomyelinaseTherapeuticTranslatingTranslational ResearchUgandaUniversitiesanakinrabaseclinical biomarkerscohortdemographicsdrug discoveryimmune activationimprovedindexingneuroimagingneuroprotectionneuroregulationnovelnovel therapeuticspre-clinicalresearch clinical testingscreeningtherapeutic developmenttherapeutic targettherapy developmenttreatment response

项目摘要

项目成果

NED C SACKTOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - CLINICAL CORE The prevalence of HAND in HIV+ individuals with advanced infection remains around 40-50%, and HAND may now be the most common form of young-age neurocognitive impairment globally. Currently there are no uniformly accepted clinical, neuroimaging, or laboratory outcome measures for clinical trials for the treatment of HAND. This Core provides the support necessary to evaluate new outcome measures of CNS function including both neurocognitive assessments (e.g., screening tests for HAND) and performance based functional assessments. In addition, the Core will provide well-characterized individuals for developmental projects such as novel neuroimaging outcomes which may be more sensitive to CNS dysfunction and response to treatment than neuropsychological test measures. The Clinical Core will also provide well-characterized individuals for evaluating novel laboratory markers identified in the Biomarker Core. Specifically, we will examine markers of cell stress, neuronal injury, and energy metabolism, which are also being used as platforms for therapeutic targets in our Therapeutic Core. The goals and objectives of this Core are as follows: 1) To maintain a clinical cohort of well-characterized HIV+ and demographically-matched HIV- individuals to improve the efficiency of accruing and conducting clinical trials, 2) To liaise with other NIMH Centers, other funded IPCPs, the AIDS Clinical Trials Group (ACTG), the Johns Hopkins University Center for AIDS Research (JHU CFAR), Institute for Clinical and Translational Research (ICTR), and the Johns Hopkins University (JHU) Drug Discovery unit to assist in the development of interventional therapeutics for HAND, 3) To provide the infrastructure and resources necessary to conduct small early phase studies to evaluate therapeutics for HAND including novel drugs, neuromodulation and behavioral strategies, 4) To maintain a data infrastructure to allow for efficient querying of clinical and laboratory data, 5) To provide statistical support for all studies involving the Center Grant resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda
  • 批准号:
    9235631
  • 项目类别:
  • 资助金额:
    $14.11万
  • 财政年份:
    2016
  • 负责人:
    NED C SACKTOR
  • 依托单位:
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda
  • 批准号:
    8458847
  • 项目类别:
  • 资助金额:
    $61.31万
  • 财政年份:
    2013
  • 负责人:
    NED C SACKTOR
  • 依托单位:
Neurologic Sequelae of HIV Subtype A and D Infection and ART Rakai Uganda
  • 批准号:
    8649088
  • 项目类别:
  • 资助金额:
    $56.8万
  • 财政年份:
    2013
  • 负责人:
    NED C SACKTOR
  • 依托单位:
HIV Dementia and Sensory Neuropathy in Uganda
  • 批准号:
    7487228
  • 项目类别:
  • 资助金额:
    $15.03万
  • 财政年份:
    2008
  • 负责人:
    NED C SACKTOR
  • 依托单位:
海外基金